| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Niki BioSolutions, Inc.
13D
NIKI · 653942102
|
51.6% |
7/24/2026
Event 7/20/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.